In autoimmune hepatitis type 1 or the autoimmune hepatitis–sclerosing cholangitis variant defective regulatory T‐cell responsiveness to IL‐2 results in low IL‐10 production and impaired suppression
Rodrigo Liberal(King's College - North Carolina), Maria Serena Longhi(Beth Israel Deaconess Medical Center), Beth Holder(NIHR Imperial Biomedical Research Centre), Diego Vergani(King's College - North Carolina), Charlotte R. Grant(King's College London), Marc Martínez‐Llordella(King's College - North Carolina), Yun Ma(King's College London), Michael A. Heneghan(King's College Hospital NHS Foundation Trust), John Cardone(King's College London), Giorgina Mieli‐Vergani(King's College London)
Cited by 103
Related Papers
International Autoimmune Hepatitis Group Report: review of criteria for diagnosis of autoimmune hepatitis
|Journal of Hepatology|1999|2.9k
The ectonucleotidases <scp>CD</scp>39 and <scp>CD</scp>73: Novel checkpoint inhibitor targets
|Immunological Reviews|2017|901
Antibodies to the Surface of Halothane-Altered Rabbit Hepatocytes in Patients with Severe Halothane-Associated Hepatitis
|New England Journal of Medicine|1980|290
Autoimmune hepatitis
|The Lancet|2013|280